Mark Kroese

999 total citations
28 papers, 633 citations indexed

About

Mark Kroese is a scholar working on Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Kroese has authored 28 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Kroese's work include BRCA gene mutations in cancer (13 papers), Genomics and Rare Diseases (10 papers) and Genetic Associations and Epidemiology (5 papers). Mark Kroese is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Genomics and Rare Diseases (10 papers) and Genetic Associations and Epidemiology (5 papers). Mark Kroese collaborates with scholars based in United Kingdom, United States and Estonia. Mark Kroese's co-authors include Ron Zimmern, Simon Sanderson, R.L. Zimmern, Hilary Burton, Gurdeep S. Sagoo, Alison Hall, Julian P. T. Higgins, Jon Emery, Christine Patch and Alison Stewart and has published in prestigious journals such as BMJ, Journal of Clinical Epidemiology and Journal of Epidemiology & Community Health.

In The Last Decade

Mark Kroese

28 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Kroese United Kingdom	14	241	203	109	94	77	28	633
Ghazi Omar Tadmouri Türkiye	14	229 1.0×	149 0.7×	116 1.1×	134 1.4×	21 0.3×	31	957
Shalu Jain India	9	90 0.4×	93 0.5×	139 1.3×	105 1.1×	21 0.3×	23	561
Virginie Hivert France	11	139 0.6×	47 0.2×	119 1.1×	99 1.1×	117 1.5×	17	624
David Westergaard Denmark	13	103 0.4×	67 0.3×	128 1.2×	184 2.0×	16 0.2×	36	699
Shawneequa Callier United States	13	308 1.3×	53 0.3×	214 2.0×	158 1.7×	35 0.5×	39	737
Chengcheng Liu China	10	53 0.2×	149 0.7×	228 2.1×	103 1.1×	15 0.2×	39	553
Holly K. Grossetta Nardini United States	16	37 0.2×	64 0.3×	79 0.7×	145 1.5×	49 0.6×	25	638
Anneliene Hechtelt Jonker France	13	256 1.1×	45 0.2×	72 0.7×	184 2.0×	83 1.1×	28	515
Anne‐Marie Laberge Canada	15	230 1.0×	215 1.1×	148 1.4×	85 0.9×	27 0.4×	55	604
Nathan Brand United States	15	122 0.5×	247 1.2×	146 1.3×	300 3.2×	70 0.9×	44	1.1k

Countries citing papers authored by Mark Kroese

Since Specialization

Citations

This map shows the geographic impact of Mark Kroese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kroese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kroese more than expected).

Fields of papers citing papers by Mark Kroese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kroese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kroese. The network helps show where Mark Kroese may publish in the future.

Co-authorship network of co-authors of Mark Kroese

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kroese. A scholar is included among the top collaborators of Mark Kroese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kroese. Mark Kroese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pezzullo, Angelo Maria, Péter Pikó, Markus Perola, et al.. (2025). A scoping review of the assessment reports of genetic or genomic tests reveals inconsistent consideration of key dimensions of clinical utility. Journal of Clinical Epidemiology. 181. 111729–111729. 1 indexed citations

Moorthie, Sowmiya, Chantal Babb de Villiers, Hilary Burton, et al.. (2022). Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention. Preventive Medicine. 159. 107075–107075. 5 indexed citations

Villiers, Chantal Babb de, Mark Kroese, & Sowmiya Moorthie. (2020). Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. Journal of Medical Genetics. 57(11). 725–732. 22 indexed citations

Hall, Alison, et al.. (2018). Risk stratification, genomic data and the law. Journal of Community Genetics. 9(3). 195–199. 3 indexed citations

Chitty, Lyn S., D. Wright, Melissa Hill, et al.. (2016). Uptake, Outcomes, and Costs of Implementing Non-invasive Prenatal Testing for Down Syndrome Into NHS Maternity Care: Prospective Cohort Study in Eight Diverse Maternity Units. Obstetrical & Gynecological Survey. 71(11). 637–639. 5 indexed citations

Chitty, Lyn S., D. Wright, Melissa Hill, et al.. (2016). Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ. 354. i3426–i3426. 109 indexed citations

Warren‐Gash, Charlotte, Mark Kroese, Hilary Burton, & Paul D.P. Pharoah. (2016). Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study. Hereditary Cancer in Clinical Practice. 14(1). 12–12. 2 indexed citations

Hill, Melissa, D. Wright, Rebecca Daley, et al.. (2014). Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy and Childbirth. 14(1). 229–229. 61 indexed citations

Kroese, Mark, et al.. (2014). Personalised medicine in the UK: challenges of implementation and impact on healthcare system. Genome Medicine. 6(4). 28–28. 8 indexed citations

10.

Kroese, Mark, et al.. (2010). A Framework for the Prioritization of Investment in the Provision of Genetic Tests. Public Health Genomics. 13(7-8). 538–543. 12 indexed citations

11.

Vivancos, Roberto, et al.. (2009). Vaccination of Poultry Workers: Delivery and Uptake of Seasonal Influenza Immunization. Zoonoses and Public Health. 58(2). 126–130. 3 indexed citations

12.

Burke, Wylie, R.L. Zimmern, & Mark Kroese. (2007). Defining purpose: a key step in genetic test evaluation. Genetics in Medicine. 9(10). 675–681. 20 indexed citations

13.

Kroese, Mark, Ron Zimmern, Peter Farndon, Fiona Stewart, & John C. Whittaker. (2007). How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network. European Journal of Human Genetics. 15(9). 917–921. 24 indexed citations

14.

Sanderson, Simon, Gurdeep S. Sagoo, Julian P. T. Higgins, et al.. (2007). Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: Systematic review meta-analysis of diagnostic and false-positive yields. Genetics in Medicine. 9(2). 74–79. 13 indexed citations

15.

Kroese, Mark, Ron Zimmern, & Sarah E. Pinder. (2007). HER2 status in breast cancer--an example of pharmacogenetic testing. Journal of the Royal Society of Medicine. 100(7). 326–329. 20 indexed citations

16.

Sanderson, Simon, Ron Zimmern, Mark Kroese, et al.. (2005). How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine. 7(7). 495–500. 83 indexed citations

17.

Kroese, Mark, Ron Zimmern, & Simon Sanderson. (2004). Genetic tests and their evaluation: Can we answer the key questions?. Genetics in Medicine. 6(6). 475–480. 25 indexed citations

18.

Burton, Hilary & Mark Kroese. (2003). Genetics. Gene genies.. PubMed. 113(5868). 29–29. 1 indexed citations

19.

Kroese, Mark, et al.. (2002). Adding insult to injury?. British Journal of Ophthalmology. 86(9). 980–980. 6 indexed citations

20.

Kroese, Mark. (2002). Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom. British Journal of Ophthalmology. 86(9). 978–980. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact